Albany Molecular Research, Inc. Breaks Ground On New R&D Centre in India
Albany Molecular Research, Inc. announced the construction of a new 50,000 sq. ft. research and development centre at the Shapoorji Pallonji Biotech Park in Hyderabad, India. The company held a groundbreaking ceremony at the site of the new facility, which represents the first major expansion of the company's Hyderabad Research Centre, a subsidiary of Albany Molecular Research, Inc.
When completed in late 2007, the new R&D center will conduct contract projects in early stage drug discovery research, including custom chemical synthesis and medicinal chemistry. In addition, the new facility will house a scale-up laboratory, which will be used to develop efficient methods for producing larger quantities of active pharmaceutical ingredients and intermediates.
When fully staffed, the new facility will add over 100 employees to the company's existing Hyderabad operations, which currently have 19 employees in the nearby ICICI Knowledge Park. The current facility can accommodate up to 40 employees and is expected to reach full capacity in the coming months.
Other news from the department business & finance
